Stock listing
Haw Par Corporation Limited
Selected listing: H02 · SGX · SGD · SG
Haw Par Corporation Limited (SGX:H02), Health Technology. Latest release Feb 27, 2026: Haw Par: Net profit rose 16.3% to S$265.5m as cost controls offset…
- Ticker
- SGX:H02
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SGX
- Currency
- SGD
About Haw Par Corporation Limited
Haw Par Corporation Limited, trading under the ticker H02, is a public company listed on the Singapore Exchange. Haw Par is known for its diverse portfolio, which includes healthcare and leisure products.
Latest news from Haw Par Corporation Limited
Haw Par: Net profit rose 16.3% to S$265.5m as cost controls offset weaker Healthcare sales
February 27, 2026
Haw Par Corporation: Net profit rose 18.2% to S$144.1m on higher revenue and investment income
August 12, 2025
Haw Par Corporation: Revenue and profit up 5% year-over-year; special dividend declared; cautious outlook
February 21, 2025
Haw Par Corporation: Net profit surged 17.1% to S$122.0m on higher revenue and investment income, despite margin pressure
August 14, 2024
Research Haw Par Corporation Limited
Haw Par Corporation Limited company profile
View the public company page for Haw Par Corporation Limited on 6ix.
Haw Par Corporation Limited news
Read company news and market updates connected to Haw Par Corporation Limited.
Haw Par Corporation Limited investor events
Find investor webinars, events, and replay context for Haw Par Corporation Limited.
Alternate listings
HAWPY:OTC
US · USD
Alternate listing for Haw Par Corporation Limited; the primary context on this page is H02:SGX.
HAWPF:OTC
US · USD
Alternate listing for Haw Par Corporation Limited; the primary context on this page is H02:SGX.
H4V:FWB
DE · EUR
Alternate listing for Haw Par Corporation Limited; the primary context on this page is H02:SGX.